Guacetisal
Jump to navigation
Jump to search
This article needs additional citations for verification. (November 2023) |
Clinical data | |
---|---|
Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.221 |
Chemical and physical data | |
Formula | C16H14O5 |
Molar mass | 286.283 g·mol−1 |
3D model (JSmol) | |
Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
|
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.[citation needed]
References
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from November 2023
- All articles needing additional references
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from February 2022
- Drugs acting on the respiratory system
- Salicylate esters
- Acetylsalicylic acids
- Catechol ethers
- All stub articles
- Respiratory system drug stubs